| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GHITM | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | C11orf95 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | ZHX3 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | FZD10 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | FAM83H | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | NIPA2 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | HECW1 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | UBE2E2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | MGST1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | GPR143 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
